Home | Site Map Font size Home › Disclosure (Transparency) › 2016 2016 Today, the openness of information is a necessary condition for the implementation of the pharmaceutical business, its culture. The interaction between pharmaceutical companies and healthcare professionals / organizations needs to be made more transparent and understandable for patients, government agencies and the general public. It is the responsibility of every pharmaceutical company, which is part of the large team of members of the Association of International Pharmaceutical Manufacturers (“AIPM”) and the European Federation of Pharmaceutical Industries and Associations (“EFPIA”), to communicate values that are passed directly or indirectly to healthcare professionals and organizations. CONTACT US: apru.transparency.dispute@astellas.com By sending an e-mail to the specified e-mail address, you confirm that you are familiar with the relevant Personal Data Processing Policy , and also consent to the transfer of any information, documents, including those containing personal data, via open Internet communication channels. Page Top 2015 2016 Russia Ukraine About company Therapeutic directions Research activities Corporate social responsibility Disclosure of information (Transparency) Contacts Mobile Site | Privacy Policy | Terms of Use | Contact Us Copyright © 2012 Astellas Pharma UK Ltd.